{"data":[{"accessionNo":"0001104659-26-097338","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1806216,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-097338","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":1806216,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-097338","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ADAR1 Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1525757,"percentOfClass":8.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-097290","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":1178203,"percentOfClass":6.75,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-097290","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":1178203,"percentOfClass":6.75,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-097290","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":1178203,"percentOfClass":6.75,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001493152-26-036565","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-05","reportingPerson":"Opaleye Management Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":2748392,"percentOfClass":13.07,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001493152-26-036565","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-05","reportingPerson":"Opaleye, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2748392,"percentOfClass":13.07,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001493152-26-036565","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-05","reportingPerson":"James Silverman","reportingCik":null,"personType":"IN","sharesOwned":2748392,"percentOfClass":13.07,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-062871","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1717009,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-062871","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"ADAR1 Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1717426,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-062871","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":1717009,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001493152-26-019071","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Orin Hirschman","reportingCik":null,"personType":"HC,IN","sharesOwned":814000,"percentOfClass":4.9,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001493152-26-019071","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":"00439U104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"AIGH Capital Management LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":814000,"percentOfClass":4.9,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-016618","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1646173,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-016618","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"ADAR1 Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1648791,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-016618","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":1646173,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-015316","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":1586659,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-015316","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":1586659,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-26-015316","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":1586659,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001493152-26-003982","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Orin Hirschman","reportingCik":null,"personType":"HC,IN","sharesOwned":907217,"percentOfClass":5.9,"filedAt":"2026-01-28","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001493152-26-003982","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"AIGH Capital Management LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":907217,"percentOfClass":5.9,"filedAt":"2026-01-28","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-25-112814","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1529200,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-25-112814","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"ADAR1 Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1534254,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"},{"accessionNo":"0001104659-25-112814","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001444192","issuerName":"Grace Therapeutics, Inc.","ticker":"GRCE","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":1529200,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/grce"}],"updatedAt":"2026-11-04T04:19:54.873Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/grce","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}